Multiple Sclerosis Agents

Random Miscellaneous Quiz

Can you name the Multiple Sclerosis Agents?

Quiz not verified by Sporcle

How to Play
Also try: Two-Syllable Blitz
Challenge
Share
Tweet
Embed
HintAnswer
Natalizumab class
Gabapentin class
Dose: IV infusion every 3 months
Dose: 1 gram/day IV for 3-5 days
Methylprednisone class
Duloxetine class
Use: Fatigue
MOA: Antimetabolite and antifolate
Use: Depression. Also helps with pain
MOA: Purine analog
Second line agent MOA: monoclonal Ab
Bupropion class
IFN beta 1-a (Rebif) class
Modafinil class
Methylphenidate class
MOA: Sphingosine 1-phosphate receptor modulator. Sequesters lymphocytes.
Dose: Oral daily (first PO MS drug)
Dose: SC injection every other day
First line RRMS agent injected SC daily
IFN beta 1-a (Avonex) class
Carbamazepine class
Use: treatment of spasticity
SE: HR reduction of 10-20 bpm, occasionally bradyarrhythmias or AV block -- screen for cardiac dz (6 hr monitoring w/ first dose). Macular edema in 1% (reversible). Check varicella
HintAnswer
Venlafaxine class
Cyclophosphamide class
Dose: SC injection 2-3 times weekly
Use: pain and paroxysmal disorders
MOA: Potassium channel blocker. Possibly increases conduction in demyelinated axons
Use: Depression. Also helps with fatigue
Fingolimod class
MOA: Anti-organ rejection drug
Mitoxantrone class
SE: Thyroid disorders, ITP (with fatal brain hemorrhage), infections.
Methotrexate class
Baclofen class
Axathioprine class
MOA: Immunomodulator/antineoplastic
Use: For pts who do not respond to corticosteroids during acute attacks
Dalfampridine class
Second line agent: RRMS. Reduced relapses & progression of disability
Plasmapheresis class
SE: Localized inj site reactions. Self-limited (15-20 min) acute rxn resembling a panic attack (palpitations, dyspnea, flushing) -- not an indication to stop tx
Rituximab class
Off line agent used in the treatment of acute attacks
Second line agent: RRMS, SPMS, Progressive Relapsing MS
Dose: IM weekly
HintAnswer
Tizanidine class
Prednisone class
SE: Risk of progressive multifocal leukoencephalopathy. Rare fatal viral (polymyxoma JC virus) reactivation infxn affecting white matter in immunosuppressed (only a risk to pts w/
SE: Seizures at higher than recommended doses (contraindicated in pts with a hx of seizure)
Dose: Oral. In extreme cases intrathecal
SE: Inj site rxn w/ high doses, flu-like s/s (responds well to naproxen), monitor liver fx, may develop neutralizing Ab, may increase depression.
MOA: alkylating agent
Second line agent for RRMS that produces reduction in progression of disabilty
Mycophenolate class
MOA: Monoclonal Ab. Shows functional improvement not just slowing of decline
IFN beta 1-b (Betaseron) class
Dose: 1250 mg/day PO for 3-5 days
Use: Fatigue, cognitive impairment (long acting agent)
Excreted by kidney: contraindicated in moderate to severe renal failure
Alemtizumab class
MOA: Immune modulator, exact mechanism not known.
Second line agent given IV monthy
Glatiramer acetate class
Daclizumab class
First line drugs for disease modification
MOA: Synthetic form of myelin basic PRO copolymer 1. Binds to MHC molecules. Competes w/ myelin antigens for presentation to T cells.
Tricyclic class

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
OR
Log In

You Might Also Like...

Show Comments

Extras